Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, UK
Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, UK
Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, UK
Faculty of Life Sciences and Medicine, School of Medical Education, Kings College London, London, UK
Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, UK
Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, UK
Department of Cancer Immunotherapeutics and Tumour Immunology, City of Hope Comprehensive Cancer Centre, Beckman Centre, Duarte, CA, USA
School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK
The Institute of Cancer Research, Chester Beatty Laboratories, London, UK
Health and Environment Theme, Institute of Environment, Health and Societies, Brunel University London, Uxbridge, UK
Copyright © 2016 Azadeh Motevalli, Hemad Yasaei, Sara Anjomani Virmouni, Morteza Mirabdulhagh, Predrag Slijepcevic, Terry Roberts et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Motevalli, A. , Yasaei, H. , Virmouni, S. , Mirabdulhagh, M. , Slijepcevic, P. and Roberts, T. (2016) Telomere Elongation in the Breast Cancer Cell Line 21NT after Treatment with an Epigenetic Modifying Drug.
Journal of Cancer Therapy,
7, 700-711. doi:
10.4236/jct.2016.710072.